Minimally Invasive Surgery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Minimally Invasive Surgery Devices Market is segmented by Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Endoscopic Devices, Laparoscopic Devices, Monitoring and Visualization Devices, Ablation Devices, Laser-based Devices, Robotic-assisted Surgical Systems, and Other MIS Devices ), Application (Aesthetic, Cardiovascular, Gastrointestinal, Gynecological, Orthopedic, Urological, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for all the above segments.

Market Snapshot

Minimally Invasive Devices Market Summary
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.88 %
Minimally Invasive Devices Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The minimally invasive surgery devices market was valued at USD 28,363.62 million in 2021, and it is expected to reach USD 42,635.94 million by 2027, registering a CAGR of 7.21% during the forecast period.

The COVID-19 pandemic has had ramifications on various surgical procedures, including minimally invasive procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases as a result of a reduction in hospital visits, which impacted the studied market. For instance, according to the research study published in August 2020, titled “Overall Impact of the COVID-19 Pandemic on Interventional Radiology Services: A Canadian Perspective”, the COVID-19 pandemic had negatively impacted the interventional radiology services in Canada, especially for elective cases, and as per the study, about 49.3% of the respondents reported that there was an overall decline in interventional radiology services in the country. Thus, this data indicates that minimally invasive surgical procedures declined due to the current pandemic scenario, which is going to affect the procurement of minimally invasive surgical procedures and devices, affecting the market. However, with the ongoing vaccinations and decreasing cases of COVID-19, the studied market is expected to bounce back to its full potential over the years.

The major factors for the growth of the minimally invasive surgery devices market include the higher acceptance rate of minimally invasive surgeries over traditional surgeries, increasing prevalence of lifestyle-related and chronic diseases, and technological advancements in the area.

The minimally invasive surgical (MIS) procedures have several advantages over conventional procedures, such as less post-operative pain, fewer major operative and post-operative complications, faster recovery times, less scarring, less stress on the immune system, and smaller incisions. These benefits of minimally invasive procedures reduce the overall hospital and the cost of the treatment, due to which MIS procedures are being preferred all over the world, driving the market growth. Further, the growing prevalence of chronic diseases such as cancer and cardiovascular diseases, among others, is further driving the demand for surgical procedures for treatment, augmenting the growth of the market. For instance, according to the World Health Organization (WHO), 2021 fact sheet, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world. As per the same source, every year, over 15 million people aged between 30-69 years die due to NCDs across the world. Thus, due to the high burden of mortality due to NCDs, the demand for treatment procedures is increasing. As minimally invasive procedures have more advantages over traditional procedures, they are gaining traction. Thus, the studied market is expected to grow over the forecast period.

Additionally, new product launches due to technological advancements, collaborations, mergers, and acquisitions are the key strategic initiatives undertaken by the industry players, which are expected to have a positive impact on the market. Thus, due to the development of innovative solutions, the market is expected to experience stable growth over the forecast period. For instance, in July 2020, Fujifilm Medical Systems USA Inc. launched its ELUXEO surgical system, which contains both the endoscopy and minimally invasive surgery portfolios of the company and helps surgeons in performing flexible and rigid endoscopy from a single tower by providing better visualization.

Also, the rising awareness about the benefits of minimally invasive procedures and increasing adoption of robotic-assisted surgery systems around the world are further expected to boost the market growth over the forecast period. However, the lack of trained professionals and uncertain regulatory policies in different parts of the world are expected to restrain the market growth during the forecast period.

Scope of the Report

As per the scope of this report, minimally invasive surgical devices refer to electrosurgical systems, robot-assisted surgical systems, and surgical equipment, which are used during the minimally invasive procedure. Minimally invasive surgery refers to any surgical procedure that is performed through tiny incisions instead of a large opening, leading to quicker recovery, minimal blood loss, and less pain than traditional open surgery.

The minimally invasive surgery devices market is segmented by product (handheld instruments, guiding devices, electrosurgical devices, endoscopic devices, laparoscopic devices, monitoring and visualization devices, ablation devices, laser-based devices, robotic-assisted surgical systems, and other MIS devices ), application (aesthetic, cardiovascular, gastrointestinal, gynecological, orthopedic, urological, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for all the above segments.

Product
Handheld Instruments
Guiding Devices
Guiding Catheters
Guidewires
Electrosurgical Devices
Endoscopic Devices
Laproscopic Devices
Monitoring and Visualization Devices
Ablation Devices
Laser-based Devices
Robotic-assisted Surgical Systems
Other MIS Devices
Application
Aesthetic
Cardiovascular
Gastrointestinal
Gynecological
Orthopedic
Urological
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Gastrointestinal Segment is Expected to Hold the Major Market Share over the Forecast Period

The gastrointestinal segment is expected to occupy a major market share and register rapid growth over the forecast period, owing to the rising incidence of gastrointestinal diseases in young, adult, and geriatric groups around the world. The gastrointestinal system in the body comprises the gastrointestinal tract, digestive tract, and alimentary canal, and the major diseases associated with the system are irritable bowel syndrome (IBS), Crohn’s disease, peptic ulcers, and others. The high burden of gastrointestinal diseases is the major factor driving the growth of the segment. For instance, according to the research study published in July 2020, titled “Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis”, the pooled prevalence of irritable bowel syndrome from a study in 38 countries was 9.2%, and IBS with mixed bowel habit had the highest prevalence with 33.8%. Thus, the high prevalence of IBS is expected to drive the growth of the gastrointestinal segment.

Further, the high prevalence of cancer related to the gastrointestinal tract, such as colon and rectum cancers, is expected to drive the demand for minimally invasive procedures, augmenting the market growth over the forecast period. For instance, as per the GLOBOCAN’s estimates in 2020, there were 1,148,515 new cases of colon cancer and 732,210 new cases of rectum cancer globally in 2020, and in recent years, minimally invasive surgeries such as laparoscopic or robot surgery have become the predominant treatment option for colon cancer, which is expected to boost the market.

Additionally, technological advances and the rise in product approvals are expected to augment the growth of the studied segment. For instance, in May 2021, EndoFresh received 510(k) clearance from the United States Food and Drug Administration of the United States for its EndoFresh Disposable Digestive Endoscopy System, which consists of a camera system with an innovative all-in-one design, disposable upper GI endoscope, and disposable colonoscope. Thus, these developments currently happening in the market are anticipated to fuel the market growth over the forecast period.

Minimally Invasive Devices Market - Colon Cancer Incidence, By Country, Global, 2020

North America is Expected to Dominate the Market Over the Forecast Period

North America held a major share of the minimally invasive surgery devices market in the past few years, and it is expected to show a similar trend over the forecast period, primarily due to the high burden of diseases requiring interventional procedures, increasing awareness about minimally invasive procedures, and growing adoption of minimally invasive devices in the region.

In North America, the United States is expected to hold a major market share during the forecast period in the studied market due to the high prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological diseases, among others. For instance, according to the updated report of the Centers for Disease Control and Prevention published in September 2021, heart disease is the leading cause of death in the United States. About 18.2 million adults of age 20 years and older have coronary artery disease, and about 360,900 people died in 2019 due to coronary heart diseases. Thus, due to the high mortality rate caused by cardiovascular diseases in the country, the number of surgeries is expected to increase. As minimally invasive surgical procedures are gaining traction, the studied market is expected to grow over the forecast period. In addition, cancer is also one of the most prevalent chronic diseases in the country, which is further expected to augment the growth of the market over the years. For instance, according to the GLOBOCAN 2020 report, 101,809 cases of colon cancer, 44,780 cases of rectum cancer, and 26,259 cases of stomach cancer were reported in the United States, which are expected to drive the demand for interventional procedures in the country.

Furthermore, technological advancements in various surgical devices from established key players in the market and new device launches are further expected to complement the growth of the market in the region. For instance, in June 2020, AnX Robotica Corporation received the De-Novo classification certification from the Food and Drug Administration for its NaviCamTM Magnetically Controlled Capsule Endoscopy (MCCE) system, which allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera. It is also remote-controlled by the physician using proprietary magnetic technologies. Further, in May 2021, the company received premarketing approval from the Food and Drug Administration for the NaviCamTM Magnetically Controlled Capsule Endoscopy (MCCE) system. Therefore, these above-mentioned factors are expected to drive the growth of the minimally invasive surgery devices market in the region.

Minimally-invasive Surgery Devices Market - Growth Rate by Region

Competitive Landscape

The market studied is moderately consolidated, owing to the presence of a few key players in the market. The companies are focusing on the technological advancement of devices to gain a significant market share. Some of the market players are Abbott Laboratories, GE Healthcare, Intuitive Surgical Inc., Koninklijke Philips NV, Medtronic PLC, Olympus Corporation, Siemens Healthineers, Smith & Nephew, Stryker Corporation, and Zimmer Biomet.

Major Players

  1. GE Healthcare

  2. Medtronic PLC

  3. Olympus Corporation

  4. Siemens Healthineers

  5. Smith & Nephew

Minimally Invasive Devices Market Concentration

Recent Developments

In April 2021, Ambu Inc. received approval from Health Canada for aScope 4 Cysto, a single-use endoscopes platform for urology.

In April 2021, Olympus Corporation, in collaboration with Veran Medical Technologies Inc., launched the US bronchoscopy portfolio of the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a line of five premium endoscopes for use in advanced diagnostic and therapeutic procedures.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Defintion

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Higher Acceptance Rate of Minimally Invasive Surgeries over Traditional Surgeries

      2. 4.2.2 Increasing Prevalence of Lifestyle-related and Chronic Disorders

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Shortage of Experienced Professionals

      2. 4.3.2 Uncertain Regulatory Framework

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

    5. 4.5 Analyst's Perspective - Impact of COVID-19 on the Market

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 Product

      1. 5.1.1 Handheld Instruments

      2. 5.1.2 Guiding Devices

        1. 5.1.2.1 Guiding Catheters

        2. 5.1.2.2 Guidewires

      3. 5.1.3 Electrosurgical Devices

      4. 5.1.4 Endoscopic Devices

      5. 5.1.5 Laproscopic Devices

      6. 5.1.6 Monitoring and Visualization Devices

      7. 5.1.7 Ablation Devices

      8. 5.1.8 Laser-based Devices

      9. 5.1.9 Robotic-assisted Surgical Systems

      10. 5.1.10 Other MIS Devices

    2. 5.2 Application

      1. 5.2.1 Aesthetic

      2. 5.2.2 Cardiovascular

      3. 5.2.3 Gastrointestinal

      4. 5.2.4 Gynecological

      5. 5.2.5 Orthopedic

      6. 5.2.6 Urological

      7. 5.2.7 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 GE Company (GE Healthcare)

      3. 6.1.3 Intuitive Surgical Inc.

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 Olympus Corporation

      7. 6.1.7 Siemens Healthineers

      8. 6.1.8 Smith & Nephew

      9. 6.1.9 Stryker Corporation

      10. 6.1.10 Zimmer Biomet Holdings Inc.

      11. 6.1.11 Johnson & Johnson Inc.

      12. 6.1.12 Renishaw PLC

      13. 6.1.13 CONMED Corporation

      14. 6.1.14 Applied Medical Resources Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Minimally Invasive Surgery Devices Market market is studied from 2019 - 2027.

The Minimally Invasive Surgery Devices Market is growing at a CAGR of 6.88% over the next 5 years.

The Minimally Invasive Surgery Devices Market is valued at 28364 Million USD in 2019.

The Minimally Invasive Surgery Devices Market is valued at 42636 Million USD in 2027.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

GE Healthcare, Medtronic PLC, Olympus Corporation, Siemens Healthineers, Smith & Nephew are the major companies operating in Minimally Invasive Surgery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!